ACEYX
Price
$10.00
Change
+$0.01 (+0.10%)
Updated
Sep 11 closing price
Net Assets
45.44M
NGCAX
Price
$36.66
Change
+$0.14 (+0.38%)
Updated
Sep 11 closing price
Net Assets
40.77M
Interact to see
Advertisement

ACEYX vs NGCAX

ACEYX vs NGCAX Comparison Chart in %
View a ticker or compare two or three
VS
ACEYX vs. NGCAX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACEYX is a Hold and NGCAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
ACEYX has more cash in the bank: 45.4M vs. NGCAX (40.8M). ACEYX pays higher dividends than NGCAX: ACEYX (4.93) vs NGCAX (2.04). ACEYX was incepted earlier than NGCAX: ACEYX (8 years) vs NGCAX (29 years). NGCAX (1.74) and ACEYX (1.72) have similar cost to investors . ACEYX is a more actively managed with annual turnover of: 113.00 vs. NGCAX (48.00). ACEYX has a lower initial minimum investment than NGCAX: ACEYX (0) vs NGCAX (2000). ACEYX annual gain was more profitable for investors over the last year : -3.37 vs. NGCAX (-16.61). ACEYX return over 5 years is better than : -9.56 vs. NGCAX (-37.01).
ACEYXNGCAXACEYX / NGCAX
Total Expense Ratio1.251.4984%
Annual Report Gross Expense Ratio1.721.7499%
Fund Existence8 years29 years-
Gain YTD-1.673-12.06414%
Front LoadN/A6%-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets45.4M40.8M111%
Annual Yield % from dividends4.932.04242%
Returns for 1 year-3.37-16.6120%
Returns for 3 years46.9515.25308%
Returns for 5 years-9.56-37.0126%
Returns for 10 yearsN/A6.19-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OSMAX38.23N/A
N/A
Invesco International Small-Mid Com A
FISPX9.49N/A
N/A
Federated Hermes Max-Cap Index IS
SPQAX17.39N/A
N/A
PGIM Jennison Global Equity Income A
CSEIX17.54N/A
N/A
Cohen & Steers Real Estate Securities A
LKSMX11.48N/A
N/A
LKCM Small-Mid Cap Equity Institutional